Search research articles
Contact Us
Filters
Showing results (291-300 of 651) with videos related to
Page
of 66
Sort By:
Inorganic Chemistry
|
October 24, 2007
S K-edge XAS and DFT calculations on square-planar NiII-thiolate complexes: effects of active and passive H-bonding
Abhishek Dey, Kayla N Green, Roxanne M Jenkins, et al.
World Journal of Hepatology
|
July 26, 2017
Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome
Angus W Jeffrey, Yi Huang, W Bastiaan de Boer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 13, 2015
A Screen of Approved Drugs Identifies the Androgen Receptor Antagonist Flutamide and Its Pharmacologically Active Metabolite 2-Hydroxy-Flutamide as Heterotropic Activators of Cytochrome P450 3A In Vitro and In Vivo
Anna L Blobaum, Frank W Byers, Thomas M Bridges, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
February 14, 2016
The Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator ADX88178 Inhibits Inflammatory Responses in Primary Microglia
Ranjani Ponnazhagan, Ashley S Harms, Aaron D Thome, et al.
Journal of Criminal Justice
|
June 6, 2020
Impact of social distancing during COVID-19 pandemic on crime in Los Angeles and Indianapolis
George Mohler, Andrea L Bertozzi, Jeremy Carter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 16, 2003
The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia
Candice E Junge, Taku Sugawara, Guido Mannaioni, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 25, 2010
Discovery of molecular switches within the ADX-47273 mGlu5 PAM scaffold that modulate modes of pharmacology to afford potent mGlu5 NAMs, PAMs and partial antagonists
Jeffrey P Lamb, Darren W Engers, Colleen M Niswender, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 17, 2010
Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part II: development of a potent and highly selective M1 PAM
Thomas M Bridges, J Phillip Kennedy, Meredith J Noetzel, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 11, 2018
Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M<sub>4</sub> Muscarinic Receptor as a Novel Therapeutic Target
Rocco G Gogliotti, Nicole M Fisher, Branden J Stansley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 10, 2007
A novel family of potent negative allosteric modulators of group II metabotropic glutamate receptors
Kamondanai Hemstapat, Herve Da Costa, Yi Nong, et al.
Page
of 66
Search research articles
Search
Showing results (291-300 of 651) with videos related to
Sort By:
Page
of 66
Inorganic Chemistry
|
October 24, 2007
S K-edge XAS and DFT calculations on square-planar NiII-thiolate complexes: effects of active and passive H-bonding
Abhishek Dey, Kayla N Green, Roxanne M Jenkins, et al.
World Journal of Hepatology
|
July 26, 2017
Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome
Angus W Jeffrey, Yi Huang, W Bastiaan de Boer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 13, 2015
A Screen of Approved Drugs Identifies the Androgen Receptor Antagonist Flutamide and Its Pharmacologically Active Metabolite 2-Hydroxy-Flutamide as Heterotropic Activators of Cytochrome P450 3A In Vitro and In Vivo
Anna L Blobaum, Frank W Byers, Thomas M Bridges, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
February 14, 2016
The Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator ADX88178 Inhibits Inflammatory Responses in Primary Microglia
Ranjani Ponnazhagan, Ashley S Harms, Aaron D Thome, et al.
Journal of Criminal Justice
|
June 6, 2020
Impact of social distancing during COVID-19 pandemic on crime in Los Angeles and Indianapolis
George Mohler, Andrea L Bertozzi, Jeremy Carter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 16, 2003
The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia
Candice E Junge, Taku Sugawara, Guido Mannaioni, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 25, 2010
Discovery of molecular switches within the ADX-47273 mGlu5 PAM scaffold that modulate modes of pharmacology to afford potent mGlu5 NAMs, PAMs and partial antagonists
Jeffrey P Lamb, Darren W Engers, Colleen M Niswender, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 17, 2010
Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part II: development of a potent and highly selective M1 PAM
Thomas M Bridges, J Phillip Kennedy, Meredith J Noetzel, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 11, 2018
Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M<sub>4</sub> Muscarinic Receptor as a Novel Therapeutic Target
Rocco G Gogliotti, Nicole M Fisher, Branden J Stansley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 10, 2007
A novel family of potent negative allosteric modulators of group II metabotropic glutamate receptors
Kamondanai Hemstapat, Herve Da Costa, Yi Nong, et al.
Page
of 66